Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL

A Kelekar1, B S Chang, J E Harlan

  • 1Gwen Knapp Center for Lupus and Immunology Research, Howard Hughes Medical Institute, The University of Chicago, Illinois 60637, USA.

Insights

The pro-apoptotic protein Bad binds to anti-apoptotic Bcl-xL, inhibiting its survival function. This interaction, mediated by Bad's BH3 domain, promotes cell death, highlighting a key mechanism in apoptosis regulation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • The Bcl-2 protein family regulates apoptosis.
  • Bad is a pro-apoptotic member that dimerizes with anti-apoptotic proteins like Bcl-xL.
  • Overexpression of Bad can overcome Bcl-xL's protective effects.

Purpose of the Study:

  • Identify the minimal domain in Bad for Bcl-xL dimerization.
  • Determine the role of dimerization in Bad's pro-apoptotic and Bcl-xL's anti-apoptotic functions.
  • Investigate the mechanism by which Bad promotes cell death.

Main Methods:

  • Deletion analysis to map the Bad-Bcl-xL interaction domain.
  • Site-directed mutagenesis of Bcl-xL's BH3-binding pocket.
  • Co-expression of Bad and Bcl-xL mutants in murine FL5.12 cells.
  • Assessment of cell survival and apoptosis in response to death signals.

Main Results:

  • A 26-amino-acid peptide in Bad, homologous to BH3 domains, is necessary and sufficient for Bcl-xL binding.
  • Mutations in Bcl-xL's BH3-binding pocket that disrupt Bad dimerization did not always abolish Bcl-xL's survival function.
  • Some Bcl-xL mutants retained protective capacity even with coexpressed Bad.

Conclusions:

  • BH3-containing proteins like Bad promote apoptosis by binding to and inhibiting anti-apoptotic Bcl-2 family members.
  • Dimerization is crucial for Bad to counteract Bcl-xL's survival function.
  • The BH3 domain of Bad is critical for its interaction with Bcl-xL and its role in apoptosis.

Related Concept Videos

Conservation of Protein Domains Over Different Proteins02:26

Conservation of Protein Domains Over Different Proteins

Protein domains are small structurally independent units that are part of a single amino acid chain.  Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to form...
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...